InsiderTrades

Form 4 for AGX ARGAN INC

Accepted 2025-05-06 00:00:00 ET · period of report 2025-04-16 · accession 0001415889-25-012112 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-05-06 2025-04-16+ AGX Baugher Joshua Scott CFO M - OptEx $0.00 +860 1,235 +229% $0
DM 2025-05-06 2025-04-16+ AGX Baugher Joshua Scott CFO M - OptEx $0.00 -1,583 4,584 -26% $0
DM 2025-05-06 2025-04-16 AGX Baugher Joshua Scott CFO A - Grant $18.03 +8,250 3,750 New +$148.7K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-04-16 M A 538 $0.00 913 D — — (F1) Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on April 16, 2024, 1,000 shares of Common Stock became issuable to the Reporting Person on April 16, 2025.
2 Common Common Stock 2025-04-17 M A 322 $0.00 1,235 D — — (F2) Pursuant to the three-year vesting schedule of the TRSU awarded to the Reporting Person on April 17, 2023, 583 shares of Common Stock became issuable to the Reporting Person on April 17, 2025.
3 Derivative Time-Based Restricted Stock Units 2025-04-16 M D 1,000 $0.00 3,167 D $0.00 · — to — 1,000 Common Stock (F1) Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on April 16, 2024, 1,000 shares of Common Stock became issuable to the Reporting Person on April 16, 2025.
4 Derivative Time-Based Restricted Stock Units 2025-04-16 A A 2,000 $0.00 5,167 D $0.00 · — to — 2,000 Common Stock (F3) On April 16, 2025, the Reporting Person was granted TRSUs covering 2,000 shares of common stock. The TRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 4/16/2026.
5 Derivative Time-Based Restricted Stock Units 2025-04-17 M D 583 $0.00 4,584 D $0.00 · — to — 583 Common Stock (F2) Pursuant to the three-year vesting schedule of the TRSU awarded to the Reporting Person on April 17, 2023, 583 shares of Common Stock became issuable to the Reporting Person on April 17, 2025.
6 Derivative Option to Purchase Common Stock 2025-04-16 A A 1,000 $148.72 2,500 D $148.72 · 2026-04-16 to 2035-04-16 1,000 Common Stock (F4) On April 16, 2025, the Reporting Person received 10-year options to purchase 1,000 shares of the Issuer's common stock with an exercise price of $148.72 per share. The options will vest ratably over three years on each anniversary of the grant date starting on 4/16/2026.
7 Derivative Performance-Based Restricted Stock Units 2025-04-16 A A 1,500 $0.00 1,500 D $0.00 · — to — 1,500 Common Stock (F5) On April 16, 2025, the Reporting Person was granted Performance-Based Restricted Stock Units ("PRSUs") in the target number of 1,500 shares, the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2025 Proxy Statement. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the target number of 1,500 shares, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.
8 Derivative Earnings Per Share Performance-Based Restricted Stock Units 2025-04-16 A A 3,750 $0.00 3,750 D $0.00 · — to — 3,750 Common Stock (F6) On April 16, 2025, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 3,750 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2026, 2027 and 2028 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2023, 2024 and 2025. The pay-out ratio of the target number of 3,750 shares, ranging from 0% to 200%, will depend on the degree of achievement of the EPS ranking at the end of the three-year performance period.